Ubs Asset Management Americas Inc Ideaya Biosciences, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 323,286 shares of IDYA stock, worth $6.71 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
323,286
Previous 318,496
1.5%
Holding current value
$6.71 Million
Previous $10.1 Million
17.65%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IDYA
# of Institutions
213Shares Held
79.9MCall Options Held
39.6KPut Options Held
24.1K-
Black Rock Inc. New York, NY6.81MShares$141 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X05.86MShares$122 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$105 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.06MShares$105 Million0.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.87MShares$80.2 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $997M
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...